NPM1 and B-cell non-Hodgkin lymphoma: Moreover, decreased expression of H1.3 is associated with a bad prognosis in acute myeloid leukemia patients with mutations in NPM1, while mutations in several RD subtypes are recurrent in B-cell lymphomas [16,44].